Cooley advised Olema Pharmaceuticals, Inc. on its private placement of approximately $130 million in common stock and a senior secured credit facility with an aggregate principal amount of up to $50 million. Jodie Bourdet and Julia Boesch led the team advising on the private placement, which included Julia Gage and Rebecca Siegel. Addison Pierce led the team advising on the credit facility, which included Margaret Barreto. Olema, whose securities trade on the Nasdaq Global Market under the symbol “OLMA,” is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for women’s cancers.
